Clinical and economic benefits of a new paradigm of HCV diagnosis and treatment

INTRODUCTION: The current paradigm (CP) of hepatitis C virus (HCV) diagnosis and treatment in Italy’s National Health Service system has numerous steps. The European Association for the Study of the Liver recommends initiation of a pan-genotypic direct-acting antiviral regimen after a simple diagnos...

Descripción completa

Detalles Bibliográficos
Autores principales: Fagiuoli, Stefano, Ruggeri, Matteo, Aragao, Filipa, Blissett, Rob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AboutScience 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616196/
https://www.ncbi.nlm.nih.gov/pubmed/36627870
http://dx.doi.org/10.33393/grhta.2021.2183

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616196/
https://www.ncbi.nlm.nih.gov/pubmed/36627870
http://dx.doi.org/10.33393/grhta.2021.2183

Ejemplares similares